DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
Author(s): Sanna Nyström | Andreas Bråve | Tina Falkeborn | Claudia Devito | Björn Rissiek | Daniel X. Johansson | Ulf Schröder | Satoshi Uematsu | Shizuo Akira | Jorma Hinkula | Steven E. Applequist
Volume: 1
Issue: 4
Year: 2013
Author(s): Sanna Nyström | Andreas Bråve | Tina Falkeborn | Claudia Devito | Björn Rissiek | Daniel X. Johansson | Ulf Schröder | Satoshi Uematsu | Shizuo Akira | Jorma Hinkula | Steven E. Applequist Volume: 1 Issue: 4 Year: 2013
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
Author(s): Julia Terhune | Erik Berk | Brian J. Czerniecki
Volume: 1
Issue: 4
Year: 2013
Author(s): Julia Terhune | Erik Berk | Brian J. Czerniecki Volume: 1 Issue: 4 Year: 2013
Chemokines as Cancer Vaccine Adjuvants
Author(s): Iuliana D. Bobanga | Agne Petrosiute | Alex Y. Huang
Volume: 1
Issue: 4
Year: 2013
Author(s): Iuliana D. Bobanga | Agne Petrosiute | Alex Y. Huang Volume: 1 Issue: 4 Year: 2013
Evaluation of Different DNA Vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) in Pigs
Author(s): Stefano Petrini | Giorgio Ramadori | Riccardo Villa | Paolo Borghetti | Elena de Angelis | Anna Maria Cantoni | Attilio Corradi | Augusto Amici | Maura Ferrari
Volume: 1
Issue: 4
Year: 2013
Author(s): Stefano Petrini | Giorgio Ramadori | Riccardo Villa | Paolo Borghetti | Elena de Angelis | Anna Maria Cantoni | Attilio Corradi | Augusto Amici | Maura Ferrari Volume: 1 Issue: 4 Year: 2013
What Has 30 Years of HIV Vaccine Research Taught Us?
Author(s): José Esparza
Volume: 1
Issue: 4
Year: 2013
Author(s): José Esparza Volume: 1 Issue: 4 Year: 2013
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial
Author(s): Larry R. Smith | Mary K. Wloch | Jennifer A. Chaplin | Michele Gerber | Alain P. Rolland
Volume: 1
Issue: 4
Year: 2013
Author(s): Larry R. Smith | Mary K. Wloch | Jennifer A. Chaplin | Michele Gerber | Alain P. Rolland Volume: 1 Issue: 4 Year: 2013
Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care
Author(s): Jennifer Young Pierce | Jeffrey E. Korte | Laura A. Carr | Catherine B. Gasper | Susan C. Modesitt
Volume: 1
Issue: 3
Year: 2013
Author(s): Jennifer Young Pierce | Jeffrey E. Korte | Laura A. Carr | Catherine B. Gasper | Susan C. Modesitt Volume: 1 Issue: 3 Year: 2013
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
Author(s): Yen Cu | Kate E. Broderick | Kaustuv Banerjee | Julie Hickman | Gillis Otten | Susan Barnett | Gleb Kichaev | Niranjan Y. Sardesai | Jeffrey B. Ulmer | Andrew Geall
Volume: 1
Issue: 3
Year: 2013
Author(s): Yen Cu | Kate E. Broderick | Kaustuv Banerjee | Julie Hickman | Gillis Otten | Susan Barnett | Gleb Kichaev | Niranjan Y. Sardesai | Jeffrey B. Ulmer | Andrew Geall Volume: 1 Issue: 3 Year: 2013
Sustaining Vaccine Confidence in the 21st Century
Author(s): Karin Hardt | Ruprecht Schmidt-Ott | Steffen Glismann | Richard A. Adegbola | François P. Meurice
Volume: 1
Issue: 3
Year: 2013
Author(s): Karin Hardt | Ruprecht Schmidt-Ott | Steffen Glismann | Richard A. Adegbola | François P. Meurice Volume: 1 Issue: 3 Year: 2013
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
Author(s): James A. Williams
Volume: 1
Issue: 3
Year: 2013
Author(s): James A. Williams Volume: 1 Issue: 3 Year: 2013
Innate Immune Signaling by, Genetic Adjuvants for, DNA Vaccination
Author(s): Kouji Kobiyama | Nao Jounai | Taiki Aoshi | Miyuki Tozuka | Fumihiko Takeshita | Cevayir Coban | Ken J. Ishii
Volume: 1
Issue: 3
Year: 2013
Author(s): Kouji Kobiyama | Nao Jounai | Taiki Aoshi | Miyuki Tozuka | Fumihiko Takeshita | Cevayir Coban | Ken J. Ishii Volume: 1 Issue: 3 Year: 2013
An HIV Vaccine for South-East Asia—Opportunities and Challenges
Author(s): Punnee Pitisuttithum | Supachai Rerks-Ngarm | Robert J. O'Connell | Jerome H. Kim | Jean-Louis Excler
Volume: 1
Issue: 3
Year: 2013
Author(s): Punnee Pitisuttithum | Supachai Rerks-Ngarm | Robert J. O'Connell | Jerome H. Kim | Jean-Louis Excler Volume: 1 Issue: 3 Year: 2013
A Multidisciplinary Research Agenda for Understanding Vaccine-Related Decisions
Author(s): Heidi Larson | Julie Leask | Sian Aggett | Nick Sevdalis | Angus Thomson
Volume: 1
Issue: 3
Year: 2013
Author(s): Heidi Larson | Julie Leask | Sian Aggett | Nick Sevdalis | Angus Thomson Volume: 1 Issue: 3 Year: 2013
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques
Author(s): Marie Borggren | Lasse Vinner | Betina Skovgaard Andresen | Berit Grevstad | Johanna Repits | Mark Melchers | Tara Laura Elvang | Rogier W Sanders | Frédéric Martinon | Nathalie Dereuddre-Bosquet | Emma Joanne Bowles | Guillaume Stewart-Jones | Priscilla Biswas | Gabriella Scarlatti | Marianne Jansson | Leo Heyndrickx | Roger Le Grand | Anders Fomsgaard
Volume: 1
Issue: 3
Year: 2013
Author(s): Marie Borggren | Lasse Vinner | Betina Skovgaard Andresen | Berit Grevstad | Johanna Repits | Mark Melchers | Tara Laura Elvang | Rogier W Sanders | Frédéric Martinon | Nathalie Dereuddre-Bosquet | Emma Joanne Bowles | Guillaume Stewart-Jones | Priscilla Biswas | Gabriella Scarlatti | Marianne Jansson | Leo Heyndrickx | Roger Le Grand | Anders Fomsgaard Volume: 1 Issue: 3 Year: 2013
Trust in Vaccines: Why It Takes More than Good Faith
Author(s): Norman Begg
Volume: 1
Issue: 3
Year: 2013
Author(s): Norman Begg Volume: 1 Issue: 3 Year: 2013
Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection
Author(s): Martyn A. French | Laila N. Abudulai | Sonia Fernandez
Volume: 1
Issue: 3
Year: 2013
Author(s): Martyn A. French | Laila N. Abudulai | Sonia Fernandez Volume: 1 Issue: 3 Year: 2013
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
Author(s): Kathleen A. Cashman | Kate E. Broderick | Eric R. Wilkinson | Carl I. Shaia | Todd M. Bell | Amy C. Shurtleff | Kristin W. Spik | Catherine V. Badger | Mary C. Guttieri | Niranjan Y. Sardesai | Connie S. Schmaljohn
Volume: 1
Issue: 3
Year: 2013
Author(s): Kathleen A. Cashman | Kate E. Broderick | Eric R. Wilkinson | Carl I. Shaia | Todd M. Bell | Amy C. Shurtleff | Kristin W. Spik | Catherine V. Badger | Mary C. Guttieri | Niranjan Y. Sardesai | Connie S. Schmaljohn Volume: 1 Issue: 3 Year: 2013
Nonclinical Development of BCG Replacement Vaccine Candidates
Author(s): Kamalakannan Velmurugan | Leander Grode | Rosemary Chang | Megan Fitzpatrick | Dominick Laddy | David Hokey | Steven Derrick | Sheldon Morris | David McCown | Reginald Kidd | Martin Gengenbacher | Bernd Eisele | Stefan H.E. Kaufmann | John Fulkerson | Michael J. Brennan
Volume: 1
Issue: 2
Year: 2013
Author(s): Kamalakannan Velmurugan | Leander Grode | Rosemary Chang | Megan Fitzpatrick | Dominick Laddy | David Hokey | Steven Derrick | Sheldon Morris | David McCown | Reginald Kidd | Martin Gengenbacher | Bernd Eisele | Stefan H.E. Kaufmann | John Fulkerson | Michael J. Brennan Volume: 1 Issue: 2 Year: 2013
Anticipated HIV Vaccine Acceptability among Sexually Active African-American Adult Women
Author(s): Julia Painter | Clare Cene-Kush | Alaina Conner | Carrie Cwiak | Lisa Haddad | Mark Mulligan | Ralph DiClemente
Volume: 1
Issue: 2
Year: 2013
Author(s): Julia Painter | Clare Cene-Kush | Alaina Conner | Carrie Cwiak | Lisa Haddad | Mark Mulligan | Ralph DiClemente Volume: 1 Issue: 2 Year: 2013
A Threat- and Efficacy-Based Framework to Understand Confidence in Vaccines among the Public Health Workforce
Author(s): Daniel J. Barnett | Nicole A. Errett | Lainie Rutkow
Volume: 1
Issue: 2
Year: 2013
Author(s): Daniel J. Barnett | Nicole A. Errett | Lainie Rutkow Volume: 1 Issue: 2 Year: 2013
Are Recent Medical Graduates More Skeptical of Vaccines?
Author(s): Michelle J. Mergler | Saad B. Omer | William K.Y. Pan | Ann Marie Navar-Boggan | Walter Orenstein | Edgar K. Marcuse | James Taylor | M. Patricia deHart | Terrell C. Carter | Anthony Damico | Neal Halsey | Daniel A. Salmon
Volume: 1
Issue: 2
Year: 2013
Author(s): Michelle J. Mergler | Saad B. Omer | William K.Y. Pan | Ann Marie Navar-Boggan | Walter Orenstein | Edgar K. Marcuse | James Taylor | M. Patricia deHart | Terrell C. Carter | Anthony Damico | Neal Halsey | Daniel A. Salmon Volume: 1 Issue: 2 Year: 2013
Kaiser Permanente Vaccine Study Center: Highlights of 2009–2012
Author(s): Roger Baxter | Nicola P. Klein
Volume: 1
Issue: 2
Year: 2013
Author(s): Roger Baxter | Nicola P. Klein Volume: 1 Issue: 2 Year: 2013
Hepatitis B Vaccination in Pregnancy in the United States
Author(s): Robert D. Stewart | Jeanne S. Sheffield
Volume: 1
Issue: 2
Year: 2013
Author(s): Robert D. Stewart | Jeanne S. Sheffield Volume: 1 Issue: 2 Year: 2013
Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003–2006 and 2007–2010
Author(s): Deanna Kruszon-Moran | R. Monina Klevens | Geraldine M. McQuillan
Volume: 1
Issue: 2
Year: 2013
Author(s): Deanna Kruszon-Moran | R. Monina Klevens | Geraldine M. McQuillan Volume: 1 Issue: 2 Year: 2013
Tumor-Associated Glycans and Immune Surveillance
Author(s): Behjatolah Monzavi-Karbassi | Anastas Pashov | Thomas Kieber-Emmons
Volume: 1
Issue: 2
Year: 2013
Author(s): Behjatolah Monzavi-Karbassi | Anastas Pashov | Thomas Kieber-Emmons Volume: 1 Issue: 2 Year: 2013
Peptide Vaccine Therapy in Colorectal Cancer
Author(s): Aleksandra Bartnik | Ajit Johnson Nirmal | Shi-Yu Yang
Volume: 1
Issue: 1
Year: 2012
Author(s): Aleksandra Bartnik | Ajit Johnson Nirmal | Shi-Yu Yang Volume: 1 Issue: 1 Year: 2012
Factors Affecting the Acceptance of Pandemic Influenza A H1N1 Vaccine amongst Essential Service Providers: A Cross Sectional Study
Author(s): Alice Beattie | Katie Palmer | Emily Rees | Zoe Riddell | Charlotte Roberts | Rachel Jordan
Volume: 1
Issue: 1
Year: 2012
Author(s): Alice Beattie | Katie Palmer | Emily Rees | Zoe Riddell | Charlotte Roberts | Rachel Jordan Volume: 1 Issue: 1 Year: 2012
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
Author(s): Carolyn M. Shoen | Michelle S. DeStefano | Cynthia C. Hager | Kyi-Toe Tham | Miriam Braunstein | Alexandria D. Allen | Hiriam O. Gates | Michael H. Cynamon | Douglas S. Kernodle
Volume: 1
Issue: 1
Year: 2013
Author(s): Carolyn M. Shoen | Michelle S. DeStefano | Cynthia C. Hager | Kyi-Toe Tham | Miriam Braunstein | Alexandria D. Allen | Hiriam O. Gates | Michael H. Cynamon | Douglas S. Kernodle Volume: 1 Issue: 1 Year: 2013
Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing
Author(s): Arthur M. Dannenberg | Bappaditya Dey
Volume: 1
Issue: 1
Year: 2013
Author(s): Arthur M. Dannenberg | Bappaditya Dey Volume: 1 Issue: 1 Year: 2013
